Patent · US Active

Stabilized liquid fosaprepitant formulations

US10307432B2 · kind B2 · utility

1Cited by
2References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 2018
Grant dateJun 4, 2019
Priority date
Expiry dateFeb 1, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to stable pharmaceutical compositions of fosaprepitant or a salt thereof in the form of ready-to-use or ready-to-dilute compositions suitable for parenteral administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.